OXBOF Stock Latest News
Company AnnouncementsOxford BioDynamics Extends Vulpes Payment Deadline in £9.15m Placing1M ago
Company AnnouncementsOxford BioDynamics Grants Over 1 Billion Share Options to CEO1M ago
Company AnnouncementsOxford BioDynamics Platform Links Fatigue Disorders Through Shared Genomic Networks1M ago
Company AnnouncementsOxford BioDynamics strengthens board with CEO Richard Compton appointment2M ago
Company AnnouncementsOxford BioDynamics Wins Shareholder Backing for Massive AIM Placing2M ago
Company AnnouncementsOxford BioDynamics strikes first Gulf deal for prostate cancer test with Dubai London Clinics2M agoCompany AnnouncementsOxford BioDynamics lands first paid deal for EpiSwitch Orion in UK psoriatic arthritis study3M ago
Company AnnouncementsOxford BioDynamics boosts test sales and launches Orion but faces funding deadline4M ago
Company AnnouncementsOxford BioDynamics expands U.S. reach with MK Commercial Group sales partnership4M ago
Company AnnouncementsOxford BioDynamics names genomics veteran Richard Compton as new CEO4M ago
Company AnnouncementsOxford BioDynamics adds Vulpes co-founder Diggle to board as it expands precision diagnostics6M ago
Company AnnouncementsOxford BioDynamics to Showcase EpiSwitch Orion at PMWC 20268M agoCompany AnnouncementsOxford BioDynamics AGM Resolutions Passed Amid Shareholder Dissent on Pay and Governance9M ago
Company AnnouncementsOxford BioDynamics Board Veteran Steps Down as Major Shareholder Retains Influence9M ago
Company AnnouncementsOxford BioDynamics Publishes 2025 Annual Report and Sets Date for AGM10M ago
Company AnnouncementsOxford BioDynamics Reports Strong Growth and Strategic Partnerships in 202510M ago
Company AnnouncementsOxford BioDynamics to Announce Year-End Financial Results10M ago
Company AnnouncementsOxford BioDynamics Reports Record Sales Amidst Screening Recommendations11M agoCompany AnnouncementsOxford BioDynamics Grants Significant Share Options to Employees and Directors11M ago



